Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MPRO Sacrifices Disputed Product

MPRO sacrifices disputed product

MicroProbe Corp. withdrew its Affirm VP line of DNA probe-based products from the market to avoid the costs of litigating a patent dispute with Gen-Probe Inc., but said it believes it can

Read the full 363 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE